These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5937350)

  • 21. [On the effectiveness of methotrexate in the treatment of psoriasis vulgaris].
    Jubin E
    Dermatologica; 1966; 132(2):76-88. PubMed ID: 5955351
    [No Abstract]   [Full Text] [Related]  

  • 22. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
    Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
    Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug reactions XV. Methotrexate, psoriasis and the liver.
    Almeyda J; Barnardo D; Baker H
    Br J Dermatol; 1971 Sep; 85(3):302-5. PubMed ID: 4939241
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring methotrexate therapy in psoriasis.
    Noojin RO; Bradford LG; Osment LS
    Arch Dermatol; 1970 Jun; 101(6):646-50. PubMed ID: 5424478
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of methotrexate in psoriasis.
    Roenigk HH; Maibach HI; Weinstein GD
    Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate for psoriasis.
    Weinstein GD
    JAMA; 1973 Jul; 225(4):412. PubMed ID: 4741015
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 28. PARENTERAL VS. ORAL FOLIC ACID ANTAGONISTS.
    AUERBACH R
    Arch Dermatol; 1964 Dec; 90():553-7. PubMed ID: 14206859
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy.
    Nyfors A; Brodthagen H
    Dermatologica; 1970; 140(6):345-55. PubMed ID: 5471371
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate therapy for psoriasis. Guideline revisions.
    Roenigk HH; Maibach HI; Weinstein GP
    Arch Dermatol; 1973 Jul; 108(1):35. PubMed ID: 4716739
    [No Abstract]   [Full Text] [Related]  

  • 31. Hazards of prolonged low-dose methotrexate therapy.
    Bender AS
    Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
    [No Abstract]   [Full Text] [Related]  

  • 32. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
    van Dooren-Greebe RJ; Kuijpers AL; Termorshuizen F; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver damage due to methotrexate in patients with psoriasis.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of psoriasis with minute divided oral doses of methotrexate.
    Spiro JM; Demis DJ
    Arch Dermatol; 1969 Apr; 99(4):459-64. PubMed ID: 4238827
    [No Abstract]   [Full Text] [Related]  

  • 35. Cirrhosis caused by methotrexate in the treatment of psoriasis.
    Muller SA; Farrow GM; Martalock DL
    Arch Dermatol; 1969 Nov; 100(5):523-30. PubMed ID: 5350402
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes of serum phosphoglycoisomerase during psoriasis therapy using Methotrexate].
    Bădănoiu A; Haisuc M; Băluş L; Coşer A
    Dermatol Monatsschr; 1972 Apr; 158(4):282-7. PubMed ID: 5029901
    [No Abstract]   [Full Text] [Related]  

  • 37. Cirrhosis associated with methotrexate treatment of psoriasis.
    Coe RO; Bull FE
    JAMA; 1968 Nov; 206(7):1515-20. PubMed ID: 5695945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with methotrexate in the management of psoriasis].
    Mazzi R
    Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural and functional abnormalities of the liver in psoriasis before and during methotrexate therapy.
    Almeyda J; Barnardo D; Baker H; Levene GM; Landells JW
    Br J Dermatol; 1972 Dec; 87(6):623-31. PubMed ID: 4648805
    [No Abstract]   [Full Text] [Related]  

  • 40. Megaloblastic anemia in the management of severe psoriasis.
    Woofter JC; Anderson PC
    W V Med J; 1975 Dec; 71(12):352-3. PubMed ID: 1060245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.